These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 28561023)

  • 21. CD226 regulates natural killer cell antitumor responses via phosphorylation-mediated inactivation of transcription factor FOXO1.
    Du X; de Almeida P; Manieri N; de Almeida Nagata D; Wu TD; Harden Bowles K; Arumugam V; Schartner J; Cubas R; Mittman S; Javinal V; Anderson KR; Warming S; Grogan JL; Chiang EY
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11731-E11740. PubMed ID: 30504141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.
    Bottino C; Castriconi R; Pende D; Rivera P; Nanni M; Carnemolla B; Cantoni C; Grassi J; Marcenaro S; Reymond N; Vitale M; Moretta L; Lopez M; Moretta A
    J Exp Med; 2003 Aug; 198(4):557-67. PubMed ID: 12913096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor.
    Tahara-Hanaoka S; Shibuya K; Kai H; Miyamoto A; Morikawa Y; Ohkochi N; Honda S; Shibuya A
    Blood; 2006 Feb; 107(4):1491-6. PubMed ID: 16249389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors.
    Gilfillan S; Chan CJ; Cella M; Haynes NM; Rapaport AS; Boles KS; Andrews DM; Smyth MJ; Colonna M
    J Exp Med; 2008 Dec; 205(13):2965-73. PubMed ID: 19029380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct receptor repertoire formation in mouse NK cell subsets regulated by MHC class I expression.
    Hayakawa Y; Watt SV; Takeda K; Smyth MJ
    J Leukoc Biol; 2008 Jan; 83(1):106-11. PubMed ID: 17940219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coordinated expression of DNAM-1 and LFA-1 in educated NK cells.
    Enqvist M; Ask EH; Forslund E; Carlsten M; Abrahamsen G; Béziat V; Andersson S; Schaffer M; Spurkland A; Bryceson Y; Önfelt B; Malmberg KJ
    J Immunol; 2015 May; 194(9):4518-27. PubMed ID: 25825444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5.
    Wang H; Qi J; Zhang S; Li Y; Tan S; Gao GF
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):988-996. PubMed ID: 30591568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.
    de Andrade LF; Smyth MJ; Martinet L
    Immunol Cell Biol; 2014 Mar; 92(3):237-44. PubMed ID: 24343663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells.
    Seth S; Georgoudaki AM; Chambers BJ; Qiu Q; Kremmer E; Maier MK; Czeloth N; Ravens I; Foerster R; Bernhardt G
    J Leukoc Biol; 2009 Jul; 86(1):91-101. PubMed ID: 19380711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis.
    Pende D; Bottino C; Castriconi R; Cantoni C; Marcenaro S; Rivera P; Spaggiari GM; Dondero A; Carnemolla B; Reymond N; Mingari MC; Lopez M; Moretta L; Moretta A
    Mol Immunol; 2005 Feb; 42(4):463-9. PubMed ID: 15607800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of DNAM-1 (CD226) on inflammatory monocytes.
    Vo AV; Takenaka E; Shibuya A; Shibuya K
    Mol Immunol; 2016 Jan; 69():70-6. PubMed ID: 26675069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNAM-1/CD155 interactions promote cytokine and NK cell-mediated suppression of poorly immunogenic melanoma metastases.
    Chan CJ; Andrews DM; McLaughlin NM; Yagita H; Gilfillan S; Colonna M; Smyth MJ
    J Immunol; 2010 Jan; 184(2):902-11. PubMed ID: 20008292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education.
    Chalifour A; Scarpellino L; Back J; Brodin P; Devèvre E; Gros F; Lévy F; Leclercq G; Höglund P; Beermann F; Held W
    Immunity; 2009 Mar; 30(3):337-47. PubMed ID: 19249231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Characterization of Novel Monoclonal Antibodies Against Human DNAM-1.
    Okumura G; Abe F; Hirochika R; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2017 Jun; 36(3):135-139. PubMed ID: 28498033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment and characterization of a novel anti-DNAM-1 monoclonal antibody.
    Yamashita Y; Abe F; Hirochika R; Tahara-Hanaoka S; Shibuya A; Shibuya K
    Monoclon Antib Immunodiagn Immunother; 2013 Feb; 32(1):60-4. PubMed ID: 23600509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.
    Kaito Y; Sugimoto E; Nakamura F; Tsukune Y; Sasaki M; Yui S; Yamaguchi H; Goyama S; Nannya Y; Mitani K; Tamura H; Imai Y
    Haematologica; 2024 Apr; 109(4):1107-1120. PubMed ID: 37731380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient mice.
    Nagumo Y; Iguchi-Manaka A; Yamashita-Kanemaru Y; Abe F; Bernhardt G; Shibuya A; Shibuya K
    PLoS One; 2014; 9(11):e112415. PubMed ID: 25384044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant deletion of SLAM-family receptors, NKG2D and DNAM-1 reveals gene redundancy of NK cell activating receptors in NK cell development and education.
    Chen S; Dong Z
    J Leukoc Biol; 2020 Apr; 107(4):561-572. PubMed ID: 31729776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the Transcriptional Regulation of MICA and PVR/CD155 Expression.
    Pignoloni B; Fionda C; Dell'Oste V; Luganini A; Cippitelli M; Zingoni A; Landolfo S; Gribaudo G; Santoni A; Cerboni C
    J Immunol; 2016 Nov; 197(10):4066-4078. PubMed ID: 27733551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.